(Q33941936)

30 July 2017

title

Hyperglycemia associated with protease inhibitors in an urban HIV-infected minority patient population (English)

1 reference

30 July 2017

0 references

1 reference

1 reference

L L Dever

1

1 reference

30 July 2017

P A Oruwari

2

1 reference

30 July 2017

W E Figueroa

3

1 reference

30 July 2017

C A O'Donovan

4

1 reference

30 July 2017

R H Eng

5

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 May 2000

1 reference

Annals of Pharmacotherapy

30 July 2017

published in

1 reference

30 July 2017

volume

34

1 reference

30 July 2017

issue

5

1 reference

30 July 2017

page(s)

580-584

1 reference

Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel

30 July 2017

cites work

1 reference

HIV-1 protease inhibitors. A review for clinicians

21 January 2018

1 reference

Crystalluria and urinary tract abnormalities associated with indinavir

21 January 2018

1 reference

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

21 January 2018

1 reference

Descriptive epidemiology of body weight and weight change in U.S. adults

21 January 2018

1 reference

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

21 January 2018

1 reference

Alcohol and the NIDDM patient

21 January 2018

1 reference

Morphine, Opioid Peptides, and Pancreatic Islet Function

21 January 2018

1 reference

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

21 January 2018

1 reference

Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study

21 January 2018

1 reference

Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients.

21 January 2018

1 reference

Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance

21 January 2018

1 reference

Insulin resistance in HIV protease inhibitor-associated diabetes

21 January 2018

1 reference

Indinavir-associated lipodystrophy.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.19231

1 reference

30 July 2017

1 reference